Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    10550143 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed OGX-427 in Castration Resistant Prostate Cancer Patients
Condition: Castration Resistant Prostate Cancer
Interventions: Drug: OGX-427;   Drug: Prednisone
2 Completed Ketoconazole Plus Docetaxel to Treat Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: Ketaconazole;   Drug: Docetaxel

Indicates status has not been verified in more than two years